1. Home
  2. BLFY vs THRD Comparison

BLFY vs THRD Comparison

Compare BLFY & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLFY
  • THRD
  • Stock Information
  • Founded
  • BLFY 1939
  • THRD 2019
  • Country
  • BLFY United States
  • THRD United States
  • Employees
  • BLFY N/A
  • THRD N/A
  • Industry
  • BLFY Commercial Banks
  • THRD Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLFY Finance
  • THRD Health Care
  • Exchange
  • BLFY Nasdaq
  • THRD Nasdaq
  • Market Cap
  • BLFY 204.2M
  • THRD 238.7M
  • IPO Year
  • BLFY N/A
  • THRD 2022
  • Fundamental
  • Price
  • BLFY $9.38
  • THRD $5.46
  • Analyst Decision
  • BLFY Hold
  • THRD Hold
  • Analyst Count
  • BLFY 2
  • THRD 3
  • Target Price
  • BLFY $11.00
  • THRD $5.00
  • AVG Volume (30 Days)
  • BLFY 60.2K
  • THRD 217.6K
  • Earning Date
  • BLFY 07-30-2025
  • THRD 08-07-2025
  • Dividend Yield
  • BLFY N/A
  • THRD N/A
  • EPS Growth
  • BLFY N/A
  • THRD N/A
  • EPS
  • BLFY N/A
  • THRD N/A
  • Revenue
  • BLFY $41,228,000.00
  • THRD N/A
  • Revenue This Year
  • BLFY $20.14
  • THRD N/A
  • Revenue Next Year
  • BLFY $20.20
  • THRD N/A
  • P/E Ratio
  • BLFY N/A
  • THRD N/A
  • Revenue Growth
  • BLFY N/A
  • THRD N/A
  • 52 Week Low
  • BLFY $8.34
  • THRD $3.18
  • 52 Week High
  • BLFY $11.48
  • THRD $16.02
  • Technical
  • Relative Strength Index (RSI)
  • BLFY 49.32
  • THRD 66.73
  • Support Level
  • BLFY $9.49
  • THRD $5.42
  • Resistance Level
  • BLFY $10.00
  • THRD $5.45
  • Average True Range (ATR)
  • BLFY 0.30
  • THRD 0.04
  • MACD
  • BLFY 0.01
  • THRD -0.01
  • Stochastic Oscillator
  • BLFY 47.01
  • THRD 50.00

About BLFY Blue Foundry Bancorp

Blue Foundry Bancorp is a full-service bank. Its business consists of originating one-to-four-family residential, multi-family, and non-residential real estate mortgages, home equity loans and lines of credit, and commercial and industrial loans. It attracts retail deposits from the general public in the areas surrounding its banking offices, through its borrowers, and through its online presence, offering a wide variety of deposit products. The bank also invests in securities. Its revenues are derived from interest on loans and, to a lesser extent, interest on mortgage-backed and other investment securities. The company's sources of funds are deposits, principal, and interest payments on loans, securities, and borrowings from the Federal Home Loan Bank of New York.

About THRD Third Harmonic Bio Inc.

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

Share on Social Networks: